Glaukos (NYSE:GKOS – Get Free Report) is scheduled to release its earnings data after the market closes on Wednesday, February 21st. Analysts expect Glaukos to post earnings of ($0.56) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link. Glaukos Stock Performance NYSE:GKOS opened […]
Shares of Glaukos Co. (NYSE:GKOS – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $94.77 and last traded at $94.52, with a volume of 172919 shares trading hands. The stock had previously closed at $91.08. Wall Street Analysts Forecast Growth Several equities analysts […]
Glaukos Co. (NYSE:GKOS – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten brokerages that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1-year target price among brokers that […]
Glaukos Co. (NYSE:GKOS – Get Free Report) COO Joseph E. Gilliam sold 9,476 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $94.12, for a total transaction of $891,881.12. Following the transaction, the chief operating officer now owns 119,802 shares of […]
Allspring Global Investments Holdings LLC raised its position in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 17.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,827 shares of the medical instruments supplier’s stock after buying an additional 270 shares during […]